BiPar Sciences Company
BiPar Sciences is a pharmacological company developing PARP inhibitors as cancer therapies.
Technology:
Medical Devices
Funding Status:
M&A
Total Funding:
$74 965 000
Last Funding Type:
Series C
Industry:
Women Cancer Treatment
Founded Date:
2002
Headquarters:
Brisbane, California, United States
Employee Number:
11-50